View Older Stories View More Recent Stories

Jul 10, 2018 04:31PM Form SC 13G/A SUNESIS PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, LLC
Jul 2, 2018 04:33PM Form SC 13D Eidos Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
Jun 26, 2018 06:00AM Precision BioSciences Raises $110M to Advance ARCUS Genome Editing Programs
Jun 21, 2018 07:30AM Crinetics Pharmaceuticals Awarded up to $3.2 Million in SBIR Grants for Congenital Hyperinsulinism and Acromegaly
Jun 19, 2018 09:01PM Form 3 Eidos Therapeutics, Inc. For: Jun 19 Filed by: RA CAPITAL MANAGEMENT, LLC
Jun 18, 2018 04:05PM Crinetics Pharmaceuticals Appoints Alan Krasner, M.D., as Chief Medical Officer
May 15, 2018 04:23PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Mar 31
Apr 30, 2018 08:00AM Synthorx Announces $63 Million Series C Financing to Advance a Pipeline of Synthorin™ Cytokines
Apr 26, 2018 05:38PM Form SC 13G/A InflaRx N.V. Filed by: RA CAPITAL MANAGEMENT, LLC
Apr 16, 2018 07:05AM Ivantis Announces Results of Landmark Prospective, Randomized Comparative MIGS Clinical Trial
Apr 12, 2018 09:05AM New Data from the HORIZON Trial of the Hydrus® Microstent Shows Significantly Lower IOP and Medication Use at 24 Months in a US Patient Cohort
Apr 5, 2018 08:00AM Eidos Therapeutics completes $64M Series B financing
Apr 4, 2018 07:30AM Arvinas Completes $55 Million Series C Financing to Advance Protein Degradation Platform
Apr 2, 2018 04:54PM Form SC 13D BIOCRYST PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, LLC
Apr 2, 2018 08:13AM RA Capital Management Opposes BioCryst Pharmaceuticals' Proposed Merger with Idera Pharmaceuticals
Apr 2, 2018 08:13AM RA Capital Management Opposes BioCryst Pharmaceuticals' Proposed Merger with Idera Pharmaceuticals
Mar 29, 2018 07:00AM InflaRx Full Year 2017 Financial & Operating Results
Mar 27, 2018 04:21PM Form SC 13D/A Dicerna Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, LLC
Mar 23, 2018 03:34PM The Economist Events Presents: "Healthcare Forum 2018: Financing Healthcare Innovation"
Mar 6, 2018 08:15AM TeraPore Technologies Raises $6M in Oversubscribed Series A Funding Round
Feb 16, 2018 04:43PM Form SC 13D/A Ra Pharmaceuticals, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2018 05:54PM Form SC 13G/A AQUINOX PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2018 05:52PM Form SC 13G ENDOCYTE INC Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2018 05:52PM Form SC 13G Spero Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2018 05:43PM Form SC 13D Kala Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2018 05:41PM Form SC 13G PROTEON THERAPEUTICS Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2018 05:40PM Form SC 13G/A ARCA biopharma, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2018 05:40PM Form SC 13G Kadmon Holdings, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2018 05:38PM Form SC 13G Krystal Biotech, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2018 05:35PM Form SC 13G/A AveXis, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2018 05:35PM Form SC 13G/A TENAX THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2018 05:35PM Form SC 13G/A Strongbridge Biopharma Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2018 05:35PM Form SC 13G/A ACHILLION PHARMACEUTICAL Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2018 05:34PM Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2018 05:34PM Form SC 13G BIOCRYST PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2018 05:34PM Form SC 13G/A ZOGENIX, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2018 05:34PM Form SC 13G Biohaven Pharmaceutical Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2018 05:21PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Dec 31
Feb 9, 2018 04:32PM Form SC 13D Solid Biosciences Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
Jan 19, 2018 05:27PM Form SC 13D/A Dicerna Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, LLC
Jan 10, 2018 04:30PM Braeburn Announces Completion of $110 Million Financing
Jan 3, 2018 08:00AM Expansion Therapeutics Raises $55.3 Million in Series A Financing to Advance Portfolio of Novel RNA Targeted Small Molecule Medicines to Treat Rare Diseases
Dec 21, 2017 06:59AM TARIS Biomedical® Announces $25M Series B Financing
Dec 20, 2017 05:30PM Form SC 13D/A Dicerna Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, LLC
Dec 15, 2017 04:31PM Form SC 13D/A Dicerna Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, LLC
Dec 11, 2017 04:31PM Form SC 13G InflaRx N.V. Filed by: RA CAPITAL MANAGEMENT, LLC
Dec 11, 2017 04:31PM Form SC 13G scPharmaceuticals Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
Nov 29, 2017 01:00PM Scientists at TSRI and Synthorx Create the First Semi-Synthetic Organism to Encode and Translate Expanded Genetic Information into a Novel Protein with Different Non-natural Amino Acids
Nov 27, 2017 09:00AM Laura Shawver, Ph.D., Appointed CEO of Synthorx
Nov 27, 2017 08:30AM Medeor Therapeutics Raises $57 Million In Series B Financing
View More Recent Stories View Older Stories